Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Peters

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Transplantation Proceedings|December 1, 1991
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantationE S Woodle, G A Perdrizet, E M Brunt, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Genes and Immunity|March 14, 2014
Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descentG L Wojcik, C L Thio, W H L Kao, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acidB Combes, R L Carithers, W C Maddrey, et al.
Hepatology (Baltimore, Md.)|August 26, 1999
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosisB Combes, R S Markin, D E Wheeler, et al.
Genes and Immunity|March 17, 2017
Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infectionsC Vergara, C Thio, R Latanich, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Transplantation Proceedings|December 1, 1991
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantationE S Woodle, G A Perdrizet, E M Brunt, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
Genes and Immunity|March 14, 2014
Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descentG L Wojcik, C L Thio, W H L Kao, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acidB Combes, R L Carithers, W C Maddrey, et al.
Hepatology (Baltimore, Md.)|August 26, 1999
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosisB Combes, R S Markin, D E Wheeler, et al.
Genes and Immunity|March 17, 2017
Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infectionsC Vergara, C Thio, R Latanich, et al.
Pageof 5